Literature DB >> 26075697

What Type of Cognitive Testing Should Be Part of Routine Electroconvulsive Therapy Practice?

Keith G Rasmussen1.   

Abstract

Several decades of research have yielded much information on the cognitive effects of electroconvulsive therapy (ECT) and have informed ECT technical factors such as electrode placement, stimulus dosing, and stimulus parameters. However, the question of what type of cognitive testing should be part of routine ECT practice has not been definitively clarified. The author reviews the recommendations, or lack thereof, in several published ECT guidelines and discusses the purposes that cognitive testing during ECT should serve and difficulties that most ECT services would encounter with intensive testing schedules. Practical utility of formal cognitive testing during and after ECT has not been satisfactorily demonstrated in ECT research. In addition, several key aspects of testing, such as cognitive domain to be tested, specific tests to be used, personnel to do the testing, time points of testing, and exactly how the test results will be interpreted and used have yet to be determined with precision. It is suggested that research efforts be undertaken to address these large gaps in ECT practice.

Mesh:

Year:  2016        PMID: 26075697     DOI: 10.1097/YCT.0000000000000257

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  5 in total

1.  Cognitive side-effects of electroconvulsive therapy: what are they, how to monitor them and what to tell patients.

Authors:  Richard J Porter; Bernhard T Baune; Grace Morris; Amber Hamilton; Darryl Bassett; Philip Boyce; Malcolm J Hopwood; Roger Mulder; Gordon Parker; Ajeet B Singh; Tim Outhred; Pritha Das; Gin S Malhi
Journal:  BJPsych Open       Date:  2020-04-17

2.  Recipients' experience with information provision for electroconvulsive therapy (ECT).

Authors:  A Coman
Journal:  BMC Psychiatry       Date:  2022-02-04       Impact factor: 3.630

Review 3.  A Systematic Review on Cognitive Effects of Electroconvulsive Therapy in Asian Patients.

Authors:  Yining Ong; Lai Gwen Chan
Journal:  Clin Psychopharmacol Neurosci       Date:  2022-02-28       Impact factor: 2.582

4.  Rivastigmine for ECT-induced cognitive adverse effects in late life depression (RECALL study): A multicenter, randomized, double blind, placebo-controlled, cross-over trial in patients with depression aged 55 years or older: Rationale, objectives and methods.

Authors:  Marieke J Henstra; Thomas C Feenstra; Rob M Kok; Harm-Pieter Spaans; Eric van Exel; Annemiek Dols; Mardien Oudega; Anton C M Vergouwen; Adriano van der Loo; Pierre M Bet; Stephan A Loer; Merijn Eikelenboom; Pascal Sienaert; Simon Lambrichts; Filip Bouckaert; Judith E Bosmans; Nathalie van der Velde; Aartjan T F Beekman; Max L Stek; Didi Rhebergen
Journal:  Front Psychiatry       Date:  2022-07-15       Impact factor: 5.435

5.  Neurocognitive profile in major depressive disorders: relationship to symptom level and subjective memory complaints.

Authors:  Christine Mohn; Bjørn Rishovd Rund
Journal:  BMC Psychiatry       Date:  2016-04-19       Impact factor: 3.630

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.